Quratis Overview
- Year Founded
-
2016
- Status
-
Public
- Employees
-
42
- Stock Symbol
-
348080
- Investments
-
1
- Share Price
-
$2.65
- (As of Friday Closing)
Quratis General Information
Description
Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.
Contact Information
Website
www.quratis.comCorporate Office
- Osong bioplant. 625-19, Yeonje-ri, Osong-eup
- Heungdeok
- Cheongju, Chungcheongbuk
- South Korea
Corporate Office
- Osong bioplant. 625-19, Yeonje-ri, Osong-eup
- Heungdeok
- Cheongju, Chungcheongbuk
- South Korea
Quratis Timeline
Quratis Stock Performance
As of 13-Nov-2026, Quratis’s stock price is $2.65. Its current market cap is $33.9M with 12.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.65 | $2.65 | $1.21 - $9.06 | $33.9M | 12.8M | 130K | -$1.78 |
Quratis Financials Summary
As of 30-Jun-2026, Quratis has a trailing 12-month revenue of $755K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 19,961 | 70,324 | 38,211 | 84,257 |
| Revenue | 755 | 1,726 | 274 | 788 |
| EBITDA | (12,218) | (15,611) | (14,573) | (7,479) |
| Net Income | (16,466) | (20,850) | (19,251) | (12,995) |
| Total Assets | 37,650 | 38,007 | 31,668 | 52,148 |
| Total Debt | 6,173 | 6,625 | 11,858 | 16,674 |
Quratis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quratis Patents
Quratis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021187932-A1 | Vaccine composition for preventing hand, foot, and mouth disease, comprising gla-se | Inactive | 20-Mar-2020 | ||
| WO-2021107548-A1 | Biomarker for diagnosis of infections or infectious diseases caused by nontuberculous mycobacteria | Inactive | 25-Nov-2019 | ||
| WO-2021107551-A1 | Biomarker for distinguishing infectious diseases caused by nontuberculous mycobacteria | Inactive | 25-Nov-2019 | ||
| WO-2021107549-A1 | Biomarker for predicting spontaneous negative conversion of bacteria after infection with nontuberculous mycobacteria | Inactive | 25-Nov-2019 | ||
| WO-2021107598-A1 | Biomarker for predicting treatment responsiveness after infection by nontuberculous mycobacteria | Inactive | 25-Nov-2019 | G01N33/68 |
Quratis Signals
Quratis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Quratis Investments (1)
Quratis’s most recent deal was a Early Stage VC with CellnLife. The deal was made on 31-May-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CellnLife | 31-May-2021 | Early Stage VC | Therapeutic Devices |
Quratis ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Quratis Exits (1)
Quratis’s most recent exit was on 31-May-2021 from CellnLife. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CellnLife | 31-May-2021 | Completed |
|
Quratis FAQs
-
When was Quratis founded?
Quratis was founded in 2016.
-
Where is Quratis headquartered?
Quratis is headquartered in Cheongju, South Korea.
-
What is the size of Quratis?
Quratis has 42 total employees.
-
What industry is Quratis in?
Quratis’s primary industry is Drug Discovery.
-
Is Quratis a private or public company?
Quratis is a Public company.
-
What is Quratis’s stock symbol?
The ticker symbol for Quratis is 348080.
-
What is the current stock price of Quratis?
As of 13-Nov-2026 the stock price of Quratis is $2.65.
-
What is the current market cap of Quratis?
The current market capitalization of Quratis is $33.9M.
-
What is Quratis’s current revenue?
The trailing twelve month revenue for Quratis is $755K.
-
What is Quratis’s annual earnings per share (EPS)?
Quratis’s EPS for 12 months was -$1.78.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process